Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
12 June 2023 |
Main ID: |
ChiCTR2300071373 |
Date of registration:
|
2023-05-12 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Effect of low frequency repetitive transcranial magnetic stimulation on sleep disturbance in patients with amyotrophic lateral sclerosis.
|
Scientific title:
|
Effect of low frequency repetitive transcranial magnetic stimulation on sleep disturbance in patients with amyotrophic lateral sclerosis. |
Date of first enrolment:
|
2023-05-12 |
Target sample size:
|
Routine rehabilitation training group + low frequency repetitive transcranial magnetic stimulation group:30;Routine rehabilitation training + low frequency repetitive transcranial magnetic stimulation sham stimulation group:30; |
Recruitment status: |
Pending |
URL:
|
https://www.chictr.org.cn/showproj.html?proj=197264 |
Study type:
|
Interventional study |
Study design:
|
Parallel
|
Phase:
|
0
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Hu yue
|
Address:
|
No. 2209, Guangxing Road, Songjiang District, Shanghai
|
Telephone:
|
+86 157 0006 0524 |
Email:
|
1303909837@qq.com |
Affiliation:
|
Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center) |
|
Name:
|
LAN dan-mei
|
Address:
|
No. 2209, Guangxing Road, Songjiang District, Shanghai
|
Telephone:
|
+86 185 2130 8136 |
Email:
|
landanmei2013@163.com |
Affiliation:
|
Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center) |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: ? The age range from 18 to 80 years old, male and female; ? All ALS patients met clinically confirmed or probable ALS in the revised E1 Escorial criteria and Pittsburgh sleep quality index (PSQI) score =7; (3) Mild to moderate disability (ALS-FRSR score: breathing score =3, other scores =2); (4) To understand the whole process of the test, voluntarily participate in and sign the informed consent, provided by or legally authorized representatives. ? Have the communication ability required to participate in all tests.
Exclusion criteria: ? Patients with unstable disease or unable to cooperate with active training; ? There are listening comprehension disorders, visual impairment, hearing impairment, complete aphasia; Cognitive dysfunction (MMSE<21); ? Had a history of major surgery a week ago; ? Patients with the following complications: 1) severe liver and kidney function injury (ALT, AST, TBiL, Cr more than 50% of the upper limit of normal); 2) Abnormal mental state; 3) Complicated with malignant tumor, or history of malignant tumor; ? Pregnant or lactating women; ? Patients with contraindications of repetitive transcranial magnetic stimulation: such as epilepsy history, metal implantation history or pacemaker implantation history; ? Other conditions in which the investigator considers it impossible to participate in the clinical trial.
Age minimum:
18
Age maximum:
80
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Amyotrophic lateral sclerosis
|
Intervention(s)
|
Routine rehabilitation training group + low frequency repetitive transcranial magnetic stimulation group:Routine rehabilitation training program, including physical therapy, occupational therapy, speech swallowing therapy, 2 times a day, 30 minutes each time, 5 times a week, 20 times. On the basis of routine intervention, repeated transcranial magnetic stimulation therapy was completed every day, with each treatment lasting 20 minutes, 5 times a week, 20 times.;Routine rehabilitation training + low frequency repetitive transcranial magnetic stimulation sham stimulation group:On the basis of routine intervention, repeated transcranial magnetic stimulation (TMS) sham stimulation was performed daily for 20 minutes, 5 times a week.;
|
Primary Outcome(s)
|
Sleep efficiency in polysomnographic monitoring data;
|
Secondary Outcome(s)
|
Hamilton depression scale score;Hamilton anxiety scale score;ALSFRS-R score;ALSAQ-40 score;
|
Source(s) of Monetary Support
|
Multidisciplinary Management of Amyotrophic lateral Sclerosis, Shanghai Disabled Persons' Federation
|
Ethics review
|
Status: Approved
Approval date: 08/02/2023
Contact:
shao ying-qi
+86 21 3773 0011
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|